FIELD: pharmacology.
SUBSTANCE: claimed is preparation for pharmacological correction of erythropoiesis disturbances, developing under cytostatic influence, - cyproheptadine. Said antiserotin preparation was introduced 30 minutes before cytostatic 5-fluoruracyl. This resulted in formation of additional areas of erytyhroid and mixed hematopoiesis.
EFFECT: cyproheptadine increased number of eryth-rocariocytes in bone marrow and reticulocytes in peripheral blood.
5 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
TREATMENT METHOD FOR HEMATOPOIETIC ERYTHROID LINEAGE DEPRESSION IN CYTOSTATIC MYELOSUPRESSION | 2008 |
|
RU2364398C1 |
MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
HAEMOSTIMULATING AGENT | 2013 |
|
RU2535021C1 |
HEMOSTIMULATING MEDICATION | 2012 |
|
RU2505308C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
MEANS FOR CORRECTION OF VIOLATIONS IN HEMOGENESIS ERYTHROID LINEAGE CAUSED BY CYSTOSTATIC IMPACT | 2016 |
|
RU2634572C1 |
Authors
Dates
2009-05-10—Published
2007-06-25—Filed